Human Vaccines & Immunotherapeutics (Oct 2020)

Co-presence of Epstein–Barr virus and high-risk human papillomaviruses in Syrian colorectal cancer samples

  • Mohammed I. Malki,
  • Ishita Gupta,
  • Queenie Fernandes,
  • Tahar Aboulkassim,
  • Amber Yasmeen,
  • Semir Vranic,
  • Ala-Eddin Al Moustafa,
  • Hamda A. Al-Thawadi

DOI
https://doi.org/10.1080/21645515.2020.1726680
Journal volume & issue
Vol. 16, no. 10
pp. 2403 – 2407

Abstract

Read online

We recently performed two studies exploring the presence of Epstein–Barr virus (EBV) and high-risk human papillomaviruses (HPVs) types 16, 18, 31, 33 and 35 in human colorectal cancers from the Syrian population. Herein, we report that EBV and high-risk HPVs are co-present in colorectal cancers from Syria. We reveal that 17 (~17%) of 102 cancer samples are positive for both EBV and high-risk HPVs and their co-presence is associated with high/intermediate grade invasive carcinomas. These data suggest that EBV and high-risk HPVs are co-present in human colorectal cancers where they might cooperate on the initiation and/or progression of these cancers. Thus, we believe that future studies are necessary to confirm the co-presence of these oncoviruses and their cooperative role in human colorectal carcinogenesis.

Keywords